Galectin-7 as a potential biomarker of Stevens-Johnson syndrome/toxic epidermal necrolysis: identification by targeted proteomics using causative drug-exposed peripheral blood cells

J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2894-2897.e7. doi: 10.1016/j.jaip.2019.05.002. Epub 2019 May 14.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Enzyme-Linked Immunosorbent Assay
  • Galectins / blood*
  • Humans
  • Leukocytes, Mononuclear / immunology
  • Proteomics
  • Severity of Illness Index
  • Stevens-Johnson Syndrome / blood*
  • Stevens-Johnson Syndrome / immunology

Substances

  • Biomarkers
  • Galectins
  • LGALS7 protein, human